{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:28:39Z","timestamp":1778858919314,"version":"3.51.4"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Fonds Cancer (FOCA) from Belgium and KU Leuven from Belgium"},{"name":"EORTC Cancer Research Fund"},{"name":"Fonds Cancer"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What are the fertility outcomes of male and female childhood acute lymphoblastic leukaemia (ALL) long-term survivors?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>We observed similar fertility outcomes in both male and female childhood ALL survivors compared with the general population, with the exception of a higher proportion of miscarriages among partners of male survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Survival after childhood ALL is currently &amp;gt;90% and fertility impairments are among the main concerns of the long-term survivors. Few studies have focused on the fertility issues within this selected population and the existing data are difficult to interpret due to the different treatment regimens received by the patients, the small sample sizes and the unavailability of control data in many studies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>Childhood ALL patients enrolled in European Organisation for Research and Treatment of Cancer (EORTC) studies between 1971 and 1998 in France and Belgium, &amp;lt;18 years old at diagnosis and alive and \u226518 years at follow-up were eligible. Among 1418 eligible survivors, 507 (35.8%) participated (277 females, 230 males). Controls from the general population matched one to one by age, province, level of urbanization and sex could be identified for 503 survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>Survivors and controls were invited to fill out a questionnaire including information about their menstrual cycles (for females), intention to have children, having children, use of medical help to become pregnant and occurrence of negative pregnancy outcomes (birth defect, miscarriage, medical abortion or stillbirth). The results were analysed separately for females and males. The association between age at diagnosis and fertility outcomes, adjusted by age at follow-up, study and country were investigated using logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>The median time since diagnosis was 20.1 years and the median age at follow-up was 25 years. There were 144 survivors (97 females, 47 males) who wanted to have children. Among these, craniospinal radiotheraphy (CRT) and haematopoietic stem cell transplantation (HSCT) were administered to 18% and 4%, respectively. Of these who tried to have children, 75% of females and 69% of males succeeded, compared with 72% and 61% of the controls, respectively. These differences were not statistically significant (P = 0.73 for females and P = 0.50 for males). Overall, fertility outcomes were comparable between survivors and controls, except that a higher proportion of miscarriages occurred in partners of male survivors (28.1% versus 5.9%, P = 0.021). Among female survivors, an older age at diagnosis (10\u201317 years) was associated with a greater risk of pregnancy problems (adjusted OR 5.61, P = 0.046).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>The interpretation of the incidence of miscarriage among the partners of male survivors is limited by the lack of data regarding the males\u2019 partners and by a possibly higher tendency to recall and disclose fertility issues among male survivors compared with male controls.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>Fertility outcomes were similar in childhood ALL survivors and controls, and the low proportion of patients treated with CRT or HSCT might explain this. Further studies should confirm the higher proportion of miscarriages in partners of male survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This publication was supported by donations from the Fonds Cancer (FOCA) from Belgium and the KU Leuven from Belgium. G.R. has been awarded a fellowship by the EORTC Cancer Research Fund (ECRF). C.P. has been awarded a fellowship by Fonds Cancer (FOCA) from Belgium and the Kinderkankerfonds from Belgium (a non-profit childhood cancer foundation under Belgian law). No competing interests were declared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                  <jats:p>NCT01298388 (clinicaltrials.gov).<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humrep\/deab236","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T13:04:30Z","timestamp":1634043870000},"page":"44-53","source":"Crossref","is-referenced-by-count":9,"title":["Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study"],"prefix":"10.1093","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4995-5161","authenticated-orcid":false,"given":"Giovanna","family":"Rossi","sequence":"first","affiliation":[{"name":"Medical Department, EORTC Headquarters, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Kicinski","sequence":"additional","affiliation":[{"name":"Statistics Department, EORTC Headquarters, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Suciu","sequence":"additional","affiliation":[{"name":"Statistics Department, EORTC Headquarters, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Els","family":"Vandecruys","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevi\u00e8ve","family":"Plat","sequence":"additional","affiliation":[{"name":"Department of Haematology, CHU Toulouse, Toulouse, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Uyttebroeck","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, University Hospital Leuven, Leuven, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Paillard","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, CHRU Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e9lissa","family":"Barbati","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, CHRU Lille, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Fran\u00e7oise","family":"Dresse","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospital Li\u00e8ge and University of Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Simon","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, CHRU Besan\u00e7on, Besan\u00e7on, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Minckes","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, CHU Caen, Caen, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Pluchart","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology and Oncology, CHU Reims, Reims, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Ferster","sequence":"additional","affiliation":[{"name":"Department of Haemato Oncology, HUDERF (ULB), Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Freycon","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, CHU Grenoble, Grenoble, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Millot","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, CHU Poitiers, Poitiers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutte","family":"van der Werff ten Bosch","sequence":"additional","affiliation":[{"name":"VUB, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Chantrain","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, CHC MontL\u00e9gia, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Paulus","sequence":"additional","affiliation":[{"name":"CHR Verviers East Belgium, Verviers, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"de Rojas","sequence":"additional","affiliation":[{"name":"Pediatric OncoGenomics & Innovation Unit, Pediatric Oncology-Hematology Department, Children\u2019s University Hospital Ni\u00f1o Jes\u00fas, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetan","family":"de Schaetzen","sequence":"additional","affiliation":[{"name":"Clinical Operation Department, EORTC Headquarters, Brussels, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Rohrlich","sequence":"additional","affiliation":[{"name":"Division of Paediatric Haematology-Oncology, CHU Nice, Nice, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yves","family":"Benoit","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology-Oncology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1442-7681","authenticated-orcid":false,"given":"Caroline","family":"Piette","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, University Hospital Li\u00e8ge and University of Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,11]]},"reference":[{"key":"2022010517003847700_deab236-B1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0027-5107(95)00039-L","article-title":"Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks","volume":"330","author":"\u03a1Anderson","year":"1995","journal-title":"Mutat Res \u2013 Fundam Mol Mech Mutagen"},{"key":"2022010517003847700_deab236-B2","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/humrep\/16.9.1838","article-title":"Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia","volume":"16","author":"\u0398Bath","year":"2001","journal-title":"Hum Reprod"},{"key":"2022010517003847700_deab236-B3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/bmt.2011.78","article-title":"Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence","volume":"47","author":"\u03a1Borgmann-Staudt","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"2022010517003847700_deab236-B4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/17446651.2019.1561271","article-title":"Long-term effects on growth, development, and metabolism of ALL treatment in childhood","volume":"14","author":"\u03a1Bruzzi","year":"2019","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2022010517003847700_deab236-B5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/pbc.10449","article-title":"Fertility of long-term male survivors of acute lymphoblastic leukemia diagnosed during childhood","volume":"42","author":"\u03a1Byrne","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"2022010517003847700_deab236-B6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pbc.20033","article-title":"Fertility in women treated with cranial radiotherapy for childhood acute lymphoblastic leukemia","volume":"42","author":"\u03a1Byrne","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"2022010517003847700_deab236-B7","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1200\/JCO.2017.76.3268","article-title":"Endocrine late effects in childhood cancer survivors","volume":"36","author":"\u03a1Chemaitilly","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort Study","volume":"33","author":"\u03a1Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B9","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1210\/jc.2006-0020","article-title":"Acute ovarian failure in the childhood cancer survivor study","volume":"91","author":"\u03a1Chemaitilly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2022010517003847700_deab236-B10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the Childhood Cancer Survivor Study cohort","volume":"17","author":"\u03a1Chow","year":"2016","journal-title":"Lancet Oncol"},{"key":"2022010517003847700_deab236-B11","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"\u03a1Clopper","year":"1934","journal-title":"Biometrika"},{"key":"2022010517003847700_deab236-B12","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.3324\/haematol.2014.103507","article-title":"Dexamethasone (6 mg\/m2\/day) and prednisolone (60 mg\/m2\/day) were equally effective as induction therapy for childhood acute lymphoblastic leukemia in the EORTC CLG 58951 randomized trial","volume":"99","author":"\u0398Domenech","year":"2014","journal-title":"Haematologica"},{"key":"2022010517003847700_deab236-B13","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/08880018.2019.1591549","article-title":"The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988\u20132010)","volume":"36","author":"\u03a1Freycon","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"key":"2022010517003847700_deab236-B14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12185-019-02627-9","article-title":"High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS)","volume":"109","author":"\u03a1Fujino","year":"2019","journal-title":"Int J Hematol"},{"key":"2022010517003847700_deab236-B15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/cncr.29133","article-title":"Experiencing reproductive concerns as a female cancer survivor is associated with depression","volume":"121","author":"\u03a1Gorman","year":"2015","journal-title":"Cancer"},{"key":"2022010517003847700_deab236-B16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2009.24.9037","article-title":"Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"28","author":"\u03a1Green","year":"2010","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B17","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"\u03a1Green","year":"2009","journal-title":"JCO"},{"key":"2022010517003847700_deab236-B18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/mob.2002.126643","article-title":"Pregnancy outcome of female survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"187","author":"\u03a1Green","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"2022010517003847700_deab236-B19","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1200\/JCO.2003.04.085","article-title":"Pregnancy outcome of partners of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"21","author":"\u03a1Green","year":"2003","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B20","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/humrep\/dex082","article-title":"Effect of cranial irradiation on sperm concentration of adult survivors of childhood acute lymphoblastic leukemia: a report from the St. Jude Lifetime Cohort Study","volume":"32","author":"\u0398Green","year":"2017","journal-title":"Hum Reprod"},{"key":"2022010517003847700_deab236-B21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/17425255.2017.1230198","article-title":"The toxicity of methotrexate in male fertility and paternal teratogenicity","volume":"13","author":"\u03a1Gutierrez","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2022010517003847700_deab236-B22","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis","author":"Harrell","year":"2001"},{"key":"2022010517003847700_deab236-B23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/014850199262625","article-title":"Male fertility in long-term survivors of childhood ALL","volume":"43","author":"\u03a1Humpl","year":"1999","journal-title":"Arch Androl"},{"key":"2022010517003847700_deab236-B24","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"\u03a1Mulder","year":"2021","journal-title":"Lancet Oncol"},{"key":"2022010517003847700_deab236-B25","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S1470-2045(20)30582-9","article-title":"Fertility preservation for male patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE Consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"22","author":"\u03a1Mulder","year":"2021","journal-title":"Lancet Oncol"},{"key":"2022010517003847700_deab236-B26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mpo.2950190603","article-title":"Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring","volume":"19","author":"\u03a1Nygaard","year":"1991","journal-title":"Med Pediatr Oncol"},{"key":"2022010517003847700_deab236-B27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcpo.2018.02.006","article-title":"Lessons learnt from the medical and psychosocial evaluation of childhood acute lymphoblastic leukemia (ALL) survivors enrolled in EORTC Children Leukemia Group Trials between 1971 and 1998 and future perspectives for long-term outcome research","volume":"15","author":"\u03a1Piette","year":"2018","journal-title":"J Cancer Policy"},{"key":"2022010517003847700_deab236-B28","first-page":"351","volume-title":"Br J Haematol","author":"\u03a1Piette","year":"2020"},{"key":"2022010517003847700_deab236-B29","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"\u03a1Pui","year":"2015","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1056\/NEJM198907203210303","article-title":"Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia","volume":"321","author":"\u03a1Quigley","year":"1989","journal-title":"N Engl J Med"},{"key":"2022010517003847700_deab236-B31","doi-asserted-by":"crossref","DOI":"10.1093\/humrep\/deab154","article-title":"Parenthood among men diagnosed with cancer in childhood and early adulthood: trends over time in a Danish national cohort","author":"Sylvest","year":"2021","journal-title":"Hum Reprod"},{"key":"2022010517003847700_deab236-B32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/humrep\/dev060","article-title":"Ovarian reserve after treatment with alkylating agents during childhood","volume":"30","author":"\u0398Thomas-Teinturier","year":"2015","journal-title":"Hum Reprod"},{"key":"2022010517003847700_deab236-B33","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/S0959-8049(02)00093-X","article-title":"Fertility and progeny","volume":"38","author":"\u03a1Thomson","year":"2002","journal-title":"Eur J Cancer"},{"key":"2022010517003847700_deab236-B34","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1200\/JCO.2011.37.1989","article-title":"Premature ovarian failure and fertility in long-term survivors of Hodgkin\u2019s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d\u2019\u00c9Tude des Lymphomes de l\u2019Adulte Cohort Study","volume":"30","author":"\u03a1van der Kaaij","year":"2012","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B35","first-page":"193","article-title":"Longitudinal follow-up in female childhood cancer survivors: no signs of accelerated ovarian function loss","volume":"32","author":"\u0398van der Kooi","year":"2017","journal-title":"Hum Reprod"},{"key":"2022010517003847700_deab236-B36","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1007\/s00432-020-03193-y","article-title":"Pregnancy, time to pregnancy and obstetric outcomes among female childhood cancer survivors: results of the DCOG LATER-VEVO study","volume":"146","author":"\u03a1van Dijk","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"2022010517003847700_deab236-B37","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"\u03a1van Dorp","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022010517003847700_deab236-B38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00520-007-0369-x","article-title":"Adult life after surviving lymphoma in childhood","volume":"16","author":"\u0398von der Weid","year":"2008","journal-title":"Support Care Cancer"},{"key":"2022010517003847700_deab236-B39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11764-014-0354-6","article-title":"Male infertility in long-term survivors of pediatric cancer: a report from the Childhood Cancer Survivor Study","volume":"8","author":"\u03a1Wasilewski-Masker","year":"2014","journal-title":"J Cancer Surviv"},{"key":"2022010517003847700_deab236-B40","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.ijrobp.2008.12.016","article-title":"Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients","volume":"73","author":"\u03a1Wo","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022010517003847700_deab236-B41","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3109\/10428194.2012.688965","article-title":"Childhood leukemia and its impact on graduation and having children: results from a national survey","volume":"53","author":"\u03a1Zynda","year":"2012","journal-title":"Leuk Lymphoma"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/1\/44\/41939354\/deab236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humrep\/article-pdf\/37\/1\/44\/41939354\/deab236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T17:05:23Z","timestamp":1641402323000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/37\/1\/44\/6425632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,11,11]]},"published-print":{"date-parts":[[2021,12,27]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deab236","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,11,11]]}}}